
Sun Pharma has seen its shares fall by 12% to an almost six-year low after it was rocked by allegations …

A new recommendation from NICE means that thousands of patients in England and Wales will be able to receive Abbvie’s …

Breast cancer patients in England and Wales now have access to another treatment option, as NICE announces its recommendation of …

As mergers and acquisitions pick up again for the New Year, Abbott has revealed plans to buy medical device firm …

MSD has unveiled new Phase 3 data for its blockbuster anti-PD-1 immunotherapy Keytruda (pembrolizumab), showing that the drug succeeded in …

DKSH’s Business Unit Performance Materials, a leading ingredients and specialty chemicals distributor, will distribute Novo Nordisk Pharmatech’s pharmaceutical grade compounds …

Verona Pharma has seen its shares crater following the Phase 2 failure of its nebulised ensifentrine, known as RPL554, in …

Breast cancer patients in Scotland are set to receive an additional treatment option, as the Scottish Medicines Consortium announces its …

Congressman Elijah Cummings has launched an investigation into pharmaceutical pricing practices.The representative for Maryland’s 7th congressional district, on Monday requested …

Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …

Seqirus has made it known that its new cell-based seasonal influenza vaccine Flucelvax Tetra has been approved by the European …

Israeli multinational Teva Pharmaceuticals has agreed to pay $135 million after being accused of fraudulently inflating wholesale prices that went …

Japanese pharma and biotech firm Kyowa Hakko Kirin is joining the growing trend of investing in artificial intelligence to bolster …

With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger merger was announced as US …

It’s only the second week of the New Year, and Johnson & Johnson has announced plans to hike the prices …